All companies › RVMD

RVMD · Revolution Medicines, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells14
Research cases0
Last filing2026-09-29

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-18 — Mancini Anthony · sold 1,764 @ $196.94 2026-09-22 — ANDERSON ELIZABETH M · sold 100 @ $195.15 2026-09-22 — ANDERSON ELIZABETH M · sold 1,500 @ $194.59 2026-09-22 — ANDERSON ELIZABETH M · sold 2,648 @ $193.44 2026-09-22 — ANDERSON ELIZABETH M · sold 4,985 @ $192.54 2026-09-22 — ANDERSON ELIZABETH M · sold 910 @ $191.85 2026-09-24 — Mancini Anthony · sold 587 @ $200.00 2026-09-25 — Cislini Jeff · sold 765 @ $207.32 2026-09-25 — Mancini Anthony · sold 3,121 @ $200.54 2026-09-29 — Sandler Alan B. · sold 2,200 @ $200.82 2026-09-29 — Sandler Alan B. · sold 1,609 @ $201.72 2026-09-29 — Sandler Alan B. · sold 1,000 @ $202.81 2026-09-29 — Sandler Alan B. · sold 1,199 @ $203.91 2026-09-29 — Sandler Alan B. · sold 301 @ $204.72
2026-09-182026-09-29

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

ANDERSON ELIZABETH M Director
Sandler Alan B. Chief Development Officer
Mancini Anthony See Remarks
Cislini Jeff SVP & General Counsel
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $RVMD is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-29', 'insider_name': 'Sandler Alan B.', 'insider_title': 'Chief Development Officer', 'transaction_type': 'Open-market sell', 'shares': 2200.0, 'price': 200.8188, 'value': 441801.36, 'is_buy': False}, {'transaction_date': '2026-09-29', 'insider_name': 'Sandler Alan B.', 'insider_title': 'Chief Development Officer', 'transaction_type': 'Open-market sell', 'shares': 1609.0, 'price': 201.7239, 'value': 324573.76, 'is_buy': False}, {'transaction_date': '2026-09-29', 'insider_name': 'Sandler Alan B.', 'insider_title': 'Chief Development Officer', 'transaction_type': 'Open-market sell', 'shares': 1000.0, 'price': 202.8127, 'value': 202812.7, 'is_buy': False}, {'transaction_date': '2026-09-29', 'insider_name': 'Sandler Alan B.', 'insider_title': 'Chief Development Officer', 'transaction_type': 'Open-market sell', 'shares': 1199.0, 'price': 203.9074, 'value': 244484.97, 'is_buy': False}, {'transaction_date': '2026-09-29', 'insider_name': 'Sandler Alan B.', 'insider_title': 'Chief Development Officer', 'transaction_type': 'Open-market sell', 'shares': 301.0, 'price': 204.7224, 'value': 61621.44, 'is_buy': False}, {'transaction_date': '2026-09-25', 'insider_name': 'Cislini Jeff', 'insider_title': 'SVP & General Counsel', 'transaction_type': 'Open-market sell', 'shares': 765.0, 'price': 207.32, 'value': 158599.8, 'is_buy': False}, {'transaction_date': '2026-09-25', 'insider_name': 'Mancini Anthony', 'insider_title': 'See Remarks', 'transaction_type': 'Open-market sell', 'shares': 3121.0, 'price': 200.54, 'value': 625885.34, 'is_buy': False}, {'transaction_date': '2026-09-24', 'insider_name': 'Mancini Anthony', 'insider_title': 'See Remarks', 'transaction_type': 'Open-market sell', 'shares': 587.0, 'price': 200.0, 'value': 117400.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'ANDERSON ELIZABETH M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 100.0, 'price': 195.15, 'value': 19515.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'ANDERSON ELIZABETH M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1500.0, 'price': 194.59, 'value': 291885.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'ANDERSON ELIZABETH M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 2648.0, 'price': 193.44, 'value': 512229.12, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'ANDERSON ELIZABETH M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 4985.0, 'price': 192.54, 'value': 959811.9, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'ANDERSON ELIZABETH M', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 910.0, 'price': 191.85, 'value': 174583.5, 'is_buy': False}, {'transaction_date': '2026-09-18', 'insider_name': 'Mancini Anthony', 'insider_title': 'See Remarks', 'transaction_type': 'Open-market sell', 'shares': 1764.0, 'price': 196.94, 'value': 347402.16, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for RVMD today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.